Author

Hersh Bendale

Stony Brook UniversityORCID 0000-0002-8582-8303Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Hersh Bendale1 paper · Stony Brook University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Amartya PaliD· 1 shared Anushka OjhaiD· 1 shared Iwao OjimaiD· 1 shared Jingfang G JuiD· 1 shared John G YueniD· 1 shared Lei Chen· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amartya PalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 10, 2026

Developing a Multimodal miR-15a Mimic to Overcome Gemcitabine and RAS(ON) Inhibitor Daraxonrasib Resistance in Pancreatic Ductal Adenocarcinoma

Amartya Pal, Anushka Ojha, John G Yuen…·Jingfang G Ju

This paper develops a multimodal miR-15a-based therapeutic that overcomes resistance to gemcitabine and daraxonrasib in PDAC by combining gene regulation and nucleotide metabolism disruption, showing potent antitumor effects in vitro and in vivo.

DOI 10.64898/2026.11.07.765071

humanproteomics

𝕏 PostBluesky